Abstract
Stress can be a predisposing factor to psychiatric disorders and has been associated with decreased neurogenesis and reduced hippocampal volume especially in depression. Similarly, in white blood cells chronic psychological stress has been associated with telomere shortening and with mood disorders and schizophrenia (SZ). However, in previous post-mortem brain studies from occipital cortex and cerebellum, no difference in telomere length was observed in depression. We hypothesized that in psychiatric disorders, stress-driven accelerated cellular aging can be observed in brain regions particularly sensitive to stress. Telomere length was measured by quantitative-PCR in five brain regions (dorsolateral prefrontal cortex, hippocampus (HIPP), amygdala, nucleus accumbens and substantia nigra (SN)) in major depressive disorder (MDD), bipolar disorder, SZ and normal control subjects (N=40, 10 subjects per group). We observed significant differences in telomere length across brain regions suggesting variable levels of cell aging, with SN and HIPP having the longest telomeres and the dorsolateral prefrontal cortex the shortest. A significant decrease (P<0.02) in telomere length was observed specifically in the HIPP of MDD subjects even after controlling for age. In the HIPP of MDD subjects, several genes involved in neuroprotection and in stress response (FKBP5, CRH) showed altered levels of mRNA. Our results suggest the presence of hippocampal stress-mediated accelerated cellular aging in depression. Further studies are needed to investigate the cellular specificity of these findings.
Similar content being viewed by others
Introduction
Telomeres are special sequences of DNA located at the end of chromosomes that preserve DNA integrity. Telomeres naturally shrink with age and cell division eventually leading to cell death.1 Shortening of telomeres can occur due to exposure to stress especially to oxidative stress, since the telomeric sequence is susceptible to oxidative damage2 and that telomeres undergo double stranded DNA breaks in the absence of replication due to oxidative stress.3 This has led to the proposition that telomere shortening can occur in cells not undergoing active mitosis, such as adult neurons, when exposed to chronic stress.4 Studies have shown that stress and increased cortisol levels can lead to the shortening of telomeres in lymphocytes5 and there is evidence for decreased telomere length in leukocytes of mood disorders and schizophrenia (SZ) patients.6, 7, 8 Most studies investigating telomere length have been performed using blood leukocytes and have shown shorter telomeres associated with major depressive disorder (MDD).4 Thus far, in brain tissue, no decrease in telomere length has been observed in studies quantifying telomere length in the cerebellum9 and the occipital cortex10 of subjects with psychiatric disorders. However, a recent study found shorter telomeres in oligodendrocytes of MDDs compared with controls in white matter from BA10 and the temporal lobe.11
Telomere length is highly dependent on the telomerase enzyme activity. This enzyme is responsible for adding the telomere repeat sequence (TTAGGG) at the 3′ end of chromosomes. Telomerase is composed of a catalytic protein component with reverse transcriptase properties (hTERT) and an RNA component (hTERC). In somatic cells, hTERT is not expressed but hTERC has been shown to be associated with telomere length. Defects in hTERC lead to shorter telomeres. Genetic variation in hTERC and has also been shown to be associated with telomere length.12, 13, 14
Telomere length is also regulated by the shelterin complex, a group of six proteins forming a cap to protect telomeres from DNA damage.15 The shelterin complex consists of TERF1 (telomeric-repeat-binding factor 1), TERF2, TIN2 (TRF1-interacting protein 2), TERF2IP (TERF2-interacting protein), POT1 (protection of telomeres 1) and, the POT1- and TIN2-organizing protein TPP1 (also known as ACD).15 Three of these proteins (TERF1, TERF2 and POT1) recognize the telomeric repeat TTAGGG while the other three proteins (TIN2, TPP1 and RAP1) serve as connectors for the first three to form the shelterin complex.15
In peripheral tissues, such as blood cells, telomere length decreases with age because of successive cell divisions.16 However, in brain tissue which is mainly composed of neurons and glia, two cell types that do not divide constantly, no correlation between age and telomere shortening has been observed in gray matter.9, 17
In this study, we investigated telomere length across five brain regions, amygdala (AMY), dorsolateral prefrontal cortex (DLPFC), hippocampus (HIPP), nucleus accumbens (NAC) and substantia nigra (SN) in subjects with neuropsychiatric disorders (MDD, bipolar disorder (BD) and SZ), and in control subjects. We hypothesized that there would be a decrease in telomere length in psychiatric disorders, possibly as a result of stress associated with psychiatric diagnoses. Furthermore, we explored the relationship between telomere length and expression levels of genes involved in telomere maintenance and in stress response.
Materials and methods
Study sample
The subjects used for this study consisted of post-mortem human brains from MDD (N=10), BD (N=10), SZ (N=10) and psychiatrically normal controls (N=10) (Table 1). The brains were collected by the University of California, Irvine Brain Bank (UCIBB) in accordance with the university’s Institutional Review Board after obtaining consent from next of kin. These brains have been characterized using the UCIBB psychological autopsy protocol, which is largely based on procedures validated by Kelly and Mann18 and has been extensively used by our group in past years.19, 20, 21, 22, 23, 24, 25 The psychological autopsy protocol enables the accurate post-mortem diagnosis of subjects based on multiple sources of information, with diagnosis being agreed on through consensus between independent clinical psychologists and a psychiatrist. For each subject, five brain regions were dissected—DLPFC, HIPP, AMY, NAC and SN. These regions were chosen due to their involvement in neuropsychiatric disorders. Dissection of the areas-of-interest was done on dry ice using neuroanatomical landmarks and being blinded to diagnostic group.
Telomere length assay
DNA was extracted specifically for this project, to avoid batch effects, from 30 mg of fresh-frozen tissue using the DNeasy Blood and Tissue DNA extraction kit (Qiagen, Valencia, CA, USA). Briefly, tissue was diced into very small pieces and incubated overnight at 56 °C in lysis buffer containing Proteinase K and subsequently column purified to obtain DNA. DNA concentration was measured using a spectrophotometer and standardized working solutions of 10 ng μl−1 were aliquoted into 96-well plates for ease of use during PCR.
Telomere length was determined using quantitative real-time PCR and a protocol based on that proposed by Cawthon.26 Specifically, two genomic assays were carried out, one for the human albumin gene (ALB), which is a single copy gene, and the other assay with primers specific to the repetitive telomeric (TEL) sequence. A ratio of the relative quantities (TEL/ALB) was then used as a quantitative measure of telomere length.
The primers used to amplify the single copy gene were: ALBF (5′-CTGTCATCTCTTGTGGGCTGT-3′) and ALBR (5′-GGCATGACAGGTTTTGCAATA-3′) and those for the telomeric sequence were: TEL1b (5′-CGGTTTGTTTGGGTTTGGGTTTGGGTTTGGGTTTGGGTT-3′) and TEL2b (5′-GGCTTGCCTTACCCTTACCCTTACCCTTACCCTTACCCT-3′). The quantitative real-time PCRs were performed on an Applied Biosystems 7900HT real-time machine (Waltham, MA, USA) in 12.5 μl reactions. The ALB quantitative PCR was run using the following cycling parameters; 95 °C for 10 min, followed by 40 cycles of denaturation at 95 °C for 15 s and annealing/extention at 60 °C for 1 min. For TEL, the quantitative PCR was run using the following cycling parameters; 95 °C for 10 min, followed by 40 cycles of denaturation at 95 °C for 15 s and annealing/extention at 56 °C for 1 min. Within each plate, a standard curve with seven data points, ranging from 40 to 0.625 ng of pooled DNA, was run and used for the calculation of reaction efficiencies for comparisons between plates. Each sample was run in triplicate and an average of the cycle thresholds was used to calculate the telomere/single copy gene (T/S) ratios as described in Cawthon.26 This method has the advantage of requiring small amounts of DNA and provides telomere length estimates that are highly correlated with mean TRF lengths as determined by Southern blot analysis.26
RNA quantification
RNA was extracted from 80 to 100 mg of tissue using Trizol reagent (Life Technologies, Carlsbad, CA, USA). Tissue was homogenized in Trizol using an Omni-Prep multisample homogenizer (Omni International, Kennesaw, GA, USA) and extracted as per the manufacturer’s protocol. RNA concentration was determined using Qubit (Life Technologies) and RNA integrity was assessed using an Agilent Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA).
RNA (5 μl at a concentration of 20 ng μl−1) was directly quantified using the NanoString nCounter analysis system (NanoString, Seattle, WA, USA). The NanoString platform allows to directly (no reverse transcription needed) and digitally quantify the number of mRNA molecules present in a sample in a highly multiplexed way (up to 800 targets) in a single reaction using color molecular barcodes. Because no complementary DNA is synthesized, RNA quantification using NanoString is less sensitive to RNA degradation and factors affecting RNA quality in paraffin-embedded samples or post-mortem samples like fixing procedures, post-mortem interval (PMI) and pH.27, 28 Samples were processed at the Genomics High-Throughput Facility of the University of California, Irvine. NanoString probes (Supplementary Table 1) were custom designed to include the following 11 telomere-associated genes: TERT, TERC, NHP2, TERF1, TINF2, TERF2, POT1, TERF2IP, nucleolar protein family A member 1 (GAR1/NOLA1), NHP2/NOLA2 and NOP10/NOLA3. We also included the following 10 stress and neuroprotection-related genes: FKBP5 (FK506-binding protein 5), CRH (corticotropin-releasing hormone), HSPA2 (heatshock 70 kDa protein 2), NR3C1 (nuclear receptor subfamily 3, group C, member 1), NR3C2, PPARA (peroxisome proliferator-activated receptor, alpha), PPARG, PPARD, RXRA (retinoid X receptor, alpha), NPY (neuropeptide Y) and GPR37 (G-protein coupled receptor 37).
Statistical analysis
Nanostring data were processed using nSolver analysis software version 1.1 from NanoString for quality control and with Partek Genomic Suite 6.6 (Partek, St-Louis, MO, USA) for normalization and statistical analysis using normalization parameters suggested by NanoString. Analysis of variance was used to investigate the effect of demographic variables, pH and PMI on telomere length and gene expression levels. Telomere length shortening between the different diagnoses and controls were also investigated by analysis of variance with and without covariates to correct for possible confounders.
Power analysis29, 30, 31 was carried out using Partek Genomics Suite 6.6 with the following parameters; control vs MDD comparison, an effect size range of 1.25 to 3.0 (by step 0.25) and a sample size ranging from 8 to 92 (by step 10). This resulted in the determination that an 80% power at a significance of 0.01 could be obtained with an N=6.
Results
Demographic variables as well as PMI and pH were not significantly different between groups (Table 1). Overall, telomere length, measured as T/S ratios, was not significantly affected by gender, PMI or pH. However, a small pH effect was found in the SN (Supplementary Table 2). Slightly negative correlations between age and telomere length were seen in each brain region (Supplementary Figure 1) but these correlations were not significant as previously reported.9, 17, 32 Brain regions showed highly significant difference in telomere length (P<0.001), with SN having the longest telomeres (average length=58.14) and DLPFC the shortest (average length=2.26) (Figure 1). No significant difference between controls and neuropsychiatric disorders for telomere length were observed in the DLPFC, AMY, NAC or SN (Table 2). A marginal increase in telomere length was observed in the AMY of SZ subjects (P=0.05, fold change=1.44). However, as expected given the changes observed in leukocytes, in the HIPP of MDDs significantly shorter telomeres were observed (P=0.0048, fold change=−1.81, Table 2 and Supplementary Figure 2) and this decrease was significant after correcting for possible confounding variable (gender, age, pH and PMI (P=0.02, fold change=−1.87, Table 2 and Supplementary Figure 2). The observed P-value (P=0.0048) passes Bonferroni correction for one tail t-test for the number of comparisons (0.1/15=0.006). Gender effects were particularly investigated when we compared controls with MDD, the interaction diagnosis × gender was not significant.
Distribution of telomere length across five brain regions in controls (C), bipolar disorder (BD), major depressive disorder (MDD) and Schizophrenia (SZ). Significant differences in average telomere length are observed across brain regions. The DLPFC has the shortest average telomere length (2.26) and the SN has the highest (58.14). In the hippocampus, we observed significantly shorter telomeres in MDD subjects compared with controls (P=0.0048, FC=−1.81). DLPFC, dorsolateral prefrontal cortex; FC, fold change; SN, substantia nigra.
Gene expression
Gene expression was investigated to explore the potential effects of telomere maintenance genes and stress-associated genes on telomere length in particular with regards to observed regional differences and those between MDDs and controls. The DLPFC and SN were the brain regions with the shortest and longest telomeres, respectively. A comparison of the RNA levels of telomere maintenance genes between these regions showed lower gene expression of several key telomere maintenance genes in the DLPFC compared with the SN (Figure 2). TERT was not detected at reliable levels which is normal for adult somatic tissue and TERF2 was not significantly different between the DLPFC and SN but other members of the telomerase complex (TERC, GAR1, DKC1, NHP2 and NOP10) and shelterin complex (TPP1, TERF1, TERF2IP, TINF2 and POT1) were expressed at higher levels in the SN when compared with the DLPFC.
Gene expression based on NanoString transcript counts for telomere maintenance genes in the DLPFC and SN in controls. Expression levels of telomere maintenance genes have lower expression in the DLPFC compared with the SN, which could be a reason for the increased telomere length seen in the SN, (**P-value⩽0.005). DLPFC, dorsolateral prefrontal cortex; SN, substantia nigra.
In the HIPP, a significant effect of diagnosis was observed for several key stress and stress response genes when comparing MDDs with controls. This effect remained significant after controlling for telomere length, age, gender, suicide, pH and PMI. The hypothesis for this comparison was that the shorter telomere length observed in the HIPP of MDDs was possibly due to gene expression alterations in telomere maintenance genes or in stress-related genes. This was found to be true especially for several stress response and neuroprotection genes, specifically FKBP5, CRH, HSPA2, PPARD, PPARG and GPR37 (Supplementary Table 1) that were significantly differentially expressed between MDDs and controls (Figure 3).
Genes found to be significantly different between MDD and controls in the hippocampus. (a) Table of P-values and fold changes for the significant genes. (b) Dot plots of genes which are involved in stress response and neuroprotection alluding to a state of heightened stress in MDDs requiring the preservation of neurons. MDD, major depressive disorder.
Discussion
We quantitatively surveyed telomere length in a cohort of psychiatric patients (MDD, BD and SZ) and normal controls and observed a significant 1.8-fold telomere length reduction in the HIPP of MDDs and also noted variable telomere length across the brain regions investigated. This is to our knowledge the first evidence linking telomere length reductions in the human HIPP to major depression. Interestingly, in a recent article Wei et al.33 also report shorter telomeres in the HIPP of a rodent genetic model of depression. Previous clinical studies have consistently observed shorter telomeres in leukocytes of mood disorder patients8 and also in SZ.6 However, studies carried out thus far in human brain tissue have not provided significant findings and have been conducted in brain regions which may be less involved in mental disorders, such as the occipital cortex10 and cerebellum.9 The current findings suggest a variable rate of cellular aging in the brain and a localized significant increase in cellular aging in the HIPP of MDD subjects, concordant with previous findings pointing to a reduction of hippocampal volume in MDD34 and in animal models of stress.35
Telomere length is negatively correlated with age especially in dividing cells such as blood.16 In this study, however, no strong correlation was observed between age and telomere length in any of the brain regions surveyed (Supplementary Figure 1). This lack of correlation is consistent with other reports using post-mortem brain samples and investigating both gray and white matter.9, 17, 32 Thus, telomere shortening with age is probably a phenomenon mainly associated with tissues containing a high ratio of dividing vs non-dividing cells which is not the case in brain tissue. Interestingly, differences in telomere length have been also observed within the same individual. In a recent study by Holstege et al.,36 telomere length was quantified in 15 tissues, including occipital cortex and whole blood, from a 115-year-old female. They observed that peripheral blood cells have the shortest telomeres while the occipital cortex has the longest, confirming the differential effect of aging on dividing vs non-dividing tissue. We observed variable telomere length also within the brain, with the DLPFC having the shortest telomeres and the SN followed by the HIPP having the longest telomeres regardless of the diagnosis (Figure 1). These results suggest that telomere shortening occurs as a consequence of cells dividing, but also suggests that other factors within the brain can contribute to the maintenance of telomere length.
Previous studies have shown that MDD diagnosis, early life adversity, maternal stress during pregnancy37 and care-giver stress all lead to significant decreases in peripheral telomere length and advanced cellular aging, for a comprehensive review see the study by Wolkowitz et al.4 Our observation of decreased telomere length in the HIPP of MDDs is of interest because (1) the HIPP, a primary limbic region, is associated with the pathophysiology of depressive disorders;38 and (2) there are reports of volumetric hippocampal decreases in MDDs compared with controls, and (3) the HIPP is a site of significant neurogenesis in the adult brain.39 The decrease in hippocampal volume in MDD may be correlated with shortening of telomeres in this brain region. It is noteworthy that shorter leukocytes telomeres have been associated with smaller hippocampal volume in imaging studies.40 To investigate the relationship between telomere maintenance/or stress response genes have on telomere length between the regions with the largest differences, we compared gene expression in DLPFC (shortest average telomere length) vs SN (longest telomere length) in control subjects to exclude any diagnosis or medication effect. We observed an overall significant decrease in telomere maintenance gene expression in the DLPFC compared with the SN. Most genes forming the telomerase complex (TERC, GAR1, DKC1, NHP2 and NOP10) and the shelterin complex (TPP1, TERF1, TERF2IP, TINF2 and POT1) were expressed at higher levels in the SN when compared with the DLPFC, possibly indicating that telomeres are better maintained in the SN. We cannot, however, exclude an effect of the ratio of dividing (glial cells) versus non-dividing cells (neurons) on observed differences in telomere length between the two regions. Other studies of telomere length of glial cells and neurons could specifically investigate that possibility.
We also compared expression of genes involved in stress response and telomere maintenance in the HIPP of MDDs and controls using a NanoString custom gene expression assay. The GPR37 and HSPA2 were found to have significantly decreased gene expression in MDDs compared with controls (Figure 3). The GPR37 gene is involved in cyclic AMP signaling and in neuroprotection,41 while HSPA2 is a chaperone and was previously shown to have significantly decreased gene expression in the DLPFC and anterior cingulate cortex of MDDs, in a different cohort, compared with controls.42, 43 Meanwhile, two nuclear receptor transcription factors (PPARD and PPARG) involved in neuroprotection, energy homeostasis, inflammation and response to oxidative stress44, 45 were expressed at higher levels in the HIPP of MDD subjects (Figure 3).
Finally, key players in regulation of the response to stress showed significantly altered gene expression in the HIPP of MDDs. FKBP5 was upregulated, while HSPA2 and CRH were downregulated in MDD subjects (Figure 3). Increased levels of FKBP5 gene expression have been previously demonstrated in the HIPP of rodents exposed to chronic mild stress46 and following treatment with dexamethasone.47, 48 Upregulation of FKBP5 gene expression is controlled by glucocorticoids 49 and has also been associated to a single nucleotide polymorphism within its intron 2, which lies within a hormone response element sensitive to glucocorticoids,50, 51 both of which could explain the increased levels observed in the present study. FKBP5 along with co-chaperones HSP90 and HSPA2 (also known as hsp70) are part of a short negative feedback loop, which regulates the glucocorticoid receptor (GR).47 Increased expression of FKBP5 has been demonstrated to retain the GR within the cytosol thus, impeding its translocation to the nucleus and subsequent activation of stress response GR-target genes.47 One of these target genes is CRH, which is considered to be a dominant regulator of the body’s physiological reaction to stressors through CRH release from the hypothalamus during times of stress,52, 53 and was found to be downregulated in MDDs in this study. The observed gene expression alterations of FKBP5, HSPA2 and the GR-target gene CRH could explain the susceptibility of the HIPP to the effects of stress and the reduction in telomere length in MDDs observed specifically in this region.
This is to our knowledge the first study to survey telomere length across five brain regions in mood disorders, SZ and controls. However, this study is not without limitations. The variability in telomere length across brain regions and the significant decrease in telomere length in MDD need to be replicated in a larger cohort. The brain is composed of a majority of dividing glial cells with significantly fewer neurons.54 Therefore, it is plausible that the observation of decreased telomere length in the HIPP of MDDs is driven by glia, although there is evidence for non-dividing cells, such as neurons, to undergo telomere shortening due to stress.2 Thus, since the method employed herein does not distinguish between glial cells and neurons further investigation of telomere length using cell-specific fractions is required. The results also connect alterations of gene expression of stress response genes in MDD and telomere shortening in the HIPP, known to have sub-regions such as the dentate gyrus able to produce new neurons in adults. More region-specific measurements within the HIPP are required to pinpoint sub-regions and types of cells more susceptible of accelerated cellular aging as measured by telomere length reductions. Finally, it would be of interest to examine this connection further by investigating additional markers of stress, such as cortisol levels and brain-specific isoforms of the GR.
In conclusion, this study shows important differences in telomere length across regions in the brains of psychiatric patients, and presents significant findings that are consistent with an advanced cellular aging in the HIPP of MDDs. This finding leads one to question the interplay between stress, neurogenesis and cellular aging on the pathophysiology of depression.
References
Blackburn EH, Greider CW, Szostak JW . Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging. Nat Med 2006; 12: 1133–1138.
Von ZT . Oxidative stress shortens telomeres. Trends Biochem Sci 2002; 27: 339–344.
Bar-Or D, Thomas GW, Rael LT, Lau EP, Winkler JV . Asp-Ala-His-Lys (DAHK) inhibits copper-induced oxidative DNA double strand breaks and telomere shortening. Biochem Biophys Res Commun 2001; 282: 356–360.
Wolkowitz OM, Epel ES, Reus VI, Mellon SH . Depression gets old fast: do stress and depression accelerate cell aging? Depress Anxiety 2010; 27: 327–338.
Choi J, Fauce SR, Effros RB . Reduced telomerase activity in human T lymphocytes exposed to cortisol. Brain Behav Immun 2008; 22: 600–605.
Kao HT, Cawthon RM, Delisi LE, Bertisch HC, Ji F, Gordon D et al. Rapid telomere erosion in schizophrenia. Mol Psychiatry 2008; 13: 118–119.
Lung FW, Chen NC, Shu BC . Genetic pathway of major depressive disorder in shortening telomeric length. Psychiatr Genet 2007; 17: 195–199.
Simon NM, Smoller JW, McNamara KL, Maser RS, Zalta AK, Pollack MH et al. Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging. Biol Psychiatry 2006; 60: 432–435.
Zhang D, Cheng L, Craig DW, Redman M, Liu C . Cerebellar telomere length and psychiatric disorders. Behav Genet 2010; 40: 250–254.
Teyssier JR, Ragot S, Donzel A, Chauvet-Gelinier JC . [Telomeres in the brain cortex of depressive patients]. Encephale 2010; 36: 491–494.
Szebeni A, Szebeni K, DiPeri T, Chandley MJ, Crawford JD, Stockmeier CA et al. Shortened telomere length in white matter oligodendrocytes in major depression: potential role of oxidative stress. Int J Neuropsychopharmacol 2014; 17: 1579–1589.
Codd V, Mangino M, van der Harst P, Braund PS, Kaiser M, Beveridge AJ et al. Common variants near TERC are associated with mean telomere length. Nat Genet 2010; 42: 197–199.
Mitchell JR, Wood E, Collins K . A telomerase component is defective in the human disease dyskeratosis congenita. Nature 1999; 402: 551–555.
Njajou OT, Blackburn EH, Pawlikowska L, Mangino M, Damcott CM, Kwok PY et al. A common variant in the telomerase RNA component is associated with short telomere length. PLoS One 2010; 5: e13048.
de LT . Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 2005; 19: 2100–2110.
Frenck RW Jr, Blackburn EH, Shannon KM . The rate of telomere sequence loss in human leukocytes varies with age. Proc Natl Acad Sci USA 1998; 95: 5607–5610.
Nakamura K, Takubo K, Izumiyama-Shimomura N, Sawabe M, Arai T, Kishimoto H et al. Telomeric DNA length in cerebral gray and white matter is associated with longevity in individuals aged 70 years or older. Exp Gerontol 2007; 42: 944–950.
Kelly TM, Mann JJ . Validity of DSM-III-R diagnosis by psychological autopsy: a comparison with clinician ante-mortem diagnosis. Acta Psychiatr Scand 1996; 94: 337–343.
Bunney WE, Bunney BG, Vawter MP, Tomita H, Li J, Evans SJ et al. Microarray technology: a review of new strategies to discover candidate vulnerability genes in psychiatric disorders. Am J Psychiatry 2003; 160: 657–666.
Choudary PV, Molnar M, Evans SJ, Tomita H, Li JZ, Vawter MP et al. Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci USA 2005; 102: 15653–15658.
Evans SJ, Choudary PV, Neal CR, Li JZ, Vawter MP, Tomita H et al. Dysregulation of the fibroblast growth factor system in major depression. Proc Natl Acad Sci USA 2004; 101: 15506–15511.
Sequeira A, Gwadry FG, Ffrench-Mullen JM, Canetti L, Gingras Y, Casero RA Jr. et al. Implication of SSAT by gene expression and genetic variation in suicide and major depression. Arch Gen Psychiatry 2006; 63: 35–48.
Sequeira A, Klempan T, Canetti L, ffrench-Mullen J, Benkelfat C, Rouleau GA et al. Patterns of gene expression in the limbic system of suicides with and without major depression. Mol Psychiatry 2007; 12: 640–655.
Sequeira A, Mamdani F, Ernst C, Vawter MP, Bunney WE, Lebel V et al. Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression. PLoS One 2009; 4: e6585.
Sequeira A, Morgan L, Walsh DM, Cartagena PM, Choudary P, Li J et al. Gene expression changes in the prefrontal cortex, anterior cingulate cortex and nucleus accumbens of mood disorders subjects that committed suicide. PLoS One 2012; 7: e35367.
Cawthon RM . Telomere measurement by quantitative PCR. Nucleic Acids Res 2002; 30: e47.
Geiss GK, Bumgarner RE, Birditt B, Dahl T, Dowidar N, Dunaway DL et al. Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotechnol 2008; 26: 317–325.
Reis PP, Waldron L, Goswami RS, Xu W, Xuan Y, Perez-Ordonez B et al. mRNA transcript quantification in archival samples using multiplexed, color-coded probes. BMC Biotechnol 2011; 11: 46.
Muller KE, Barton CN, Benignus VA . Recommendations for appropriate statistical practice in toxicologic experiments. Neurotoxicology 1984; 5: 113–125.
Muller KE, Benignus VA . Increasing scientific power with statistical power. Neurotoxicol Teratol 1992; 14: 211–219.
Muller KE, Lavange LM, Ramey SL, Ramey CT . Power calculations for general linear multivariate models including repeated measures applications. J Am Stat Assoc 1992; 87: 1209–1226.
Hudson G, Faini D, Stutt A, Eccles M, Robinson L, Burn DJ et al. No evidence of substantia nigra telomere shortening in Parkinson's disease. Neurobiol Aging 2011; 32: 2107–5.
Wei Y, Backlund L, Wegener G, Mathe AA, Lavebratt C . Telomerase dysregulation in the hippocampus of a rat model of depression. Normalization by lithium. Int J Neuropsychopharmacol 2015; 18: pyv002.
Drevets WC, Videen TO, Price JL, Preskorn SH, Carmichael ST, Raichle ME . A functional anatomical study of unipolar depression. J Neurosci 1992; 12: 3628–3641.
McEwen BS . Brain on stress: how the social environment gets under the skin. Proc Natl Acad Sci USA 2012; 109: 17180–17185.
Holstege H, Pfeiffer W, Sie D, Hulsman M, Nicholas TJ, Lee CC et al. Somatic mutations found in the healthy blood compartment of a 115-yr-old woman demonstrate oligoclonal hematopoiesis. Genome Res 2014; 24: 733–742.
Entringer S, Epel ES, Kumsta R, Lin J, Hellhammer DH, Blackburn EH et al. Stress exposure in intrauterine life is associated with shorter telomere length in young adulthood. Proc Natl Acad Sci USA 2011; 108: e513–e518.
Warner-Schmidt JL, Duman RS . Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment. Hippocampus 2006; 16: 239–249.
Eriksson PS, Perfilieva E, Bjork-Eriksson T, Alborn AM, Nordborg C, Peterson DA et al. Neurogenesis in the adult human hippocampus. Nat Med 1998; 4: 1313–1317.
Jacobs EG, Epel ES, Lin J, Blackburn EH, Rasgon NL . Relationship between leukocyte telomere length, telomerase activity, and hippocampal volume in early aging. JAMA Neurol 2014; 71: 921–923.
Meyer RC, Giddens MM, Schaefer SA, Hall RA . GPR37 and GPR37L1 are receptors for the neuroprotective and glioprotective factors prosaptide and prosaposin. Proc Natl Acad Sci USA 2013; 110: 9529–9534.
Tomita H, Ziegler ME, Kim HB, Evans SJ, Choudary PV, Li JZ et al. G protein-linked signaling pathways in bipolar and major depressive disorders. Front Genet 2013; 4: 297.
Vawter MP, Tomita H, Meng F, Bolstad B, Li J, Evans S et al. Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders. Mol Psychiatry 2006; 11: 615, 663–679.
Polvani S, Tarocchi M, Galli A . PPARgamma and oxidative stress: con(beta) catenating NRF2 and FOXO. PPAR Res 2012; 2012: 641087.
Schnegg CI, Robbins ME . Neuroprotective mechanisms of ppardelta: modulation of oxidative stress and inflammatory processes. PPAR Res 2011; 2011: 373560.
Guidotti G, Calabrese F, Anacker C, Racagni G, Pariante CM, Riva MA . Glucocorticoid receptor and FKBP5 expression is altered following exposure to chronic stress: modulation by antidepressant treatment. Neuropsychopharmacology 2013; 38: 616–627.
Binder EB . The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology 2009; 34: S186–S195.
Scharf SH, Liebl C, Binder EB, Schmidt MV, Muller MB . Expression and regulation of the Fkbp5 gene in the adult mouse brain. PLoS One 2011; 6: e16883.
Vermeer H, Hendriks-Stegeman BI, van der Burg B, van Buul-Offers SC, Jansen M . Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: a potential marker for glucocorticoid sensitivity, potency, and bioavailability. J Clin Endocrinol Metab 2003; 88: 277–284.
Binder EB, Salyakina D, Lichtner P, Wochnik GM, Ising M, Putz B et al. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet 2004; 36: 1319–1325.
Hubler TR, Scammell JG . Intronic hormone response elements mediate regulation of FKBP5 by progestins and glucocorticoids. Cell Stress Chaperones 2004; 9: 243–252.
Binder EB, Nemeroff CB . The CRF system, stress, depression and anxiety-insights from human genetic studies. Mol Psychiatry 2010; 15: 574–588.
Naughton M, Dinan TG, Scott LV . Corticotropin-releasing hormone and the hypothalamic-pituitary-adrenal axis in psychiatric disease. Handb Clin Neurol 2014; 124C: 69–91.
Bear MF, Connors P, Paradiso M Neuroscience: Exploring The Brain, 3rd edn. Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2006..
Acknowledgements
We are members of the Pritzker Neuropsychiatric Disorders Research Consortium, which is supported by the Pritzker Neuropsychiatric Disorders Research Fund. A shared intellectual property agreement exists between this philanthropic fund and the University of Michigan, Stanford University, the Weill Medical College of Cornell University, HudsonAlpha Institute of Biotechnology, the Universities of California at Davis and at Irvine, to encourage the development of appropriate findings for research and clinical applications. The research was further supported by The Brain & Behavior Research Foundation (former NARSAD) Young Investigator Award (AFS) and by NIMH research grant R01MH097082 (AFS).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Translational Psychiatry website
Supplementary information
Rights and permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Mamdani, F., Rollins, B., Morgan, L. et al. Variable telomere length across post-mortem human brain regions and specific reduction in the hippocampus of major depressive disorder. Transl Psychiatry 5, e636 (2015). https://doi.org/10.1038/tp.2015.134
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/tp.2015.134
- Springer Nature Limited
This article is cited by
-
Strong associations of telomere length and mitochondrial copy number with suicidality and abuse history in adolescent depressed individuals
Molecular Psychiatry (2023)
-
An alternative extension of telomeres related prognostic model to predict survival in lower grade glioma
Journal of Cancer Research and Clinical Oncology (2023)
-
Identification of potential blood biomarkers associated with suicide in major depressive disorder
Translational Psychiatry (2022)
-
Stress reactivity elicits a tissue-specific reduction in telomere length in aging zebrafish (Danio rerio)
Scientific Reports (2021)
-
Towards precision medicine for stress disorders: diagnostic biomarkers and targeted drugs
Molecular Psychiatry (2020)